Palbociclib Intermediate CAS 1016636-76-2 Mimo>99.0% (HPLC) Aworan Ifihan Factory

Palbociclib Intermediate CAS 1016636-76-2 Mimọ>99.0% (HPLC) Ile-iṣẹ

Apejuwe kukuru:

Orukọ Kemikali: 6-Bromo-2-Chloro-8-Cyclopentyl-5-Methylpyrido-[2,3-d]pyrimidin-7(8H) -ọkan

CAS: 1016636-76-2

Mimọ:> 99.0% (HPLC)

Irisi: Funfun si Light Yellow Powder

Agbedemeji ti Palbociclib (CAS: 571190-30-2)

Didara to gaju, iṣelọpọ Iṣowo

E-Mail: alvin@ruifuchem.com

Fi imeeli ranṣẹ si wa

Alaye ọja

Jẹmọ Products

ọja Tags

Apejuwe:

Ipese Kemikali Ruifu Palbociclib Awọn agbedemeji ibatan:
Palbociclib CAS 571190-30-2
5-Bromo-2,4-Dichloropyrimidine CAS 36082-50-5
5-Bromo-2-Chloro-N-Cyclopentylpyrimidin-4-Amine CAS 733039-20-8
tert-Butyl 4-(6-Nitropyridin-3-yl) piperazine-1-Carboxylate CAS 571189-16-7
tert-Butyl 4-(6-Amino-3-Pyridyl)piperazine-1-Carboxylate CAS 571188-59-5
6-Bromo-2-Chloro-8-Cyclopentyl-5-Methylpyrido-[2,3-d]pyrimidin-7(8H) -ọkan CAS 1016636-76-2
2-Chloro-8-Cyclopentyl-5-Methyl-8H-Pyrido[2,3-d]pyrimidin-7-ọkan CAS 1013916-37-4

Kemikali Properties:

Orukọ Kemikali	6-Bromo-2-Chloro-8-Cyclopentyl-5-Methylpyrido-[2,3-d]pyrimidin-7(8H) -ọkan
Awọn itumọ ọrọ sisọ	Palbociclib-Pb3
Nọmba CAS	1016636-76-2
NỌMBA CAT	RF-PI1849
Iṣura Ipo	Ninu Iṣura, Iwọn iṣelọpọ Ti o to Awọn Toonu
Ilana molikula	C13H13BrClN3O
Òṣuwọn Molikula	342.63
Brand	Ruifu Kemikali

Awọn pato:

Nkan	Awọn pato
Ifarahan	Funfun to Light Yellow Powder
Mimọ / Analysis Ọna	> 99.0% (HPLC)
Awọn nkan ti o jọmọ	<1.00%
Pipadanu lori Gbigbe	<0.50%
Omi (KF)	<0.50%
Igbeyewo Standard	Standard Enterprise
Lilo	Agbedemeji ti Palbociclib (CAS: 571190-30-2)

Package & Ibi ipamọ:

Package: Igo, apo bankanje aluminiomu, 25kg / Paali ilu, tabi gẹgẹ bi ibeere alabara

Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina ati ọrinrin

Awọn anfani:

FAQ:

Ohun elo:

6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido-[2,3-d] pyrimidin-7 (8H) -ọkan (CAS: 1016636-76-2) jẹ agbedemeji ti Palbociclib (CAS: 571190- 30-2).Palbociclib jẹ oogun fun itọju ER-positive ati HER2-negative akàn igbaya ti o ni idagbasoke.Palbociclib jẹ oludena yiyan ti awọn kinases ti o gbẹkẹle cyclin CDK4 ati CDK6.Ni Oṣu Kẹta Ọjọ 3, Ọdun 2015, US FDA fọwọsi Pfizer's Palbociclib (orukọ iṣowo: Ibrance) fun itọju ti akàn igbaya to ti ni ilọsiwaju/metastatic ninu awọn obinrin postmenopausal.Palbociclib jẹ oludena CDK4/6 akọkọ lati gba ifọwọsi FDA.